The Enfamil Similac lawsuit is one of the largest product liability cases in American history, and it’s picking up serious momentum in 2026. Thousands of families allege that cow’s milk based formulas from Abbott and Mead Johnson caused necrotizing enterocolitis in premature infants.
As of early 2026, more than 1,000 cases are consolidated in federal court. Bellwether trials have produced mixed results, and settlement talks are underway for qualifying families.
This article breaks down everything you need to know: who qualifies, how much compensation to expect, filing deadlines, trial results, and exactly what steps to take right now. One fact worth knowing: studies suggest premature infants fed cow’s milk formula face up to 10 times the NEC risk compared to those receiving breast milk.
What Is the Enfamil Similac Lawsuit?
The Enfamil Similac lawsuit is a mass tort legal action against the makers of two popular baby formulas. Families claim these products caused a devastating intestinal disease called necrotizing enterocolitis, or NEC, in premature babies.
NEC destroys the lining of a newborn’s intestines. It can lead to emergency surgery, permanent organ damage, and death. Premature infants in the NICU are the most vulnerable population.
The core allegation is straightforward: Abbott Laboratories (Similac) and Mead Johnson Nutrition (Enfamil) knew their cow’s milk based products posed an elevated NEC risk to preterm infants. Despite that knowledge, they kept selling these products to NICUs without adequate warnings.
| Quick Facts | Details |
|---|---|
| Lawsuit Type | Mass tort, product liability |
| Products Named | Similac, Enfamil (multiple product lines) |
| Defendants | Abbott Laboratories, Mead Johnson/Reckitt Benckiser |
| Condition Alleged | Necrotizing Enterocolitis (NEC) |
| Court | Northern District of Illinois |
| MDL Number | 3026 |
Parents didn’t get the information they needed to make informed choices. That’s the heart of every single claim in this litigation.
The lawsuit isn’t about formula being “bad” in general. It’s specifically about whether manufacturers had a duty to warn that their cow’s milk products carried a known NEC risk for premature babies. Families say yes, and the evidence is stacking up in their favor.
NEC Lawsuit 2026 Update
The NEC lawsuit is entering a decisive phase in 2026. Bellwether trials are shaping the future of this litigation, and settlement discussions have intensified behind the scenes.
By early 2026, more than 1,000 individual lawsuits are part of MDL No. 3026. Judge Rebecca R. Pallmeyer continues to oversee the consolidated proceedings in the Northern District of Illinois.
The first bellwether trial in 2024 resulted in a significant jury verdict against Mead Johnson. A second trial produced a defense verdict for Abbott. These split results are common in mass tort litigation and don’t determine the outcome for every case.
What matters right now is momentum. Both sides are evaluating their positions based on bellwether outcomes. Settlement frameworks are being discussed, though no global settlement has been announced yet.
- More than 1,000 cases pending in MDL 3026 as of 2026
- Bellwether trials have produced mixed verdicts
- Settlement talks are ongoing but no formal deal is public
- New filings continue to be accepted into the MDL
- Discovery is largely complete for the initial wave of cases
If you’re waiting to file, 2026 is not the year to sit on the sidelines. The litigation window is open, but deadlines vary by state.
The pace of this lawsuit has accelerated significantly since 2024. Families who file now still have time to be included in any future settlement framework.
The Enfamil and Similac Lawsuit Explained
The Enfamil and Similac lawsuit centers on one core failure: the manufacturers did not warn parents and hospitals about the NEC risk for premature babies. Medical literature has flagged this risk for decades, yet formula labels stayed silent.
Mead Johnson makes Enfamil. Abbott makes Similac. Both companies produce specialized product lines marketed directly to NICUs and hospitals caring for premature infants.
Products like Similac Special Care and Enfamil NeuroPro EnfaCare are designed for low birth weight babies. These are the exact products at issue. They contain cow’s milk proteins that research has linked to higher NEC rates in preterm infants.
Think of it like a seatbelt manufacturer knowing their product fails during certain types of crashes but choosing not to tell drivers. The product works fine for most people, but a specific, identifiable group faces serious danger.
Families argue they would have chosen donor breast milk or other alternatives if they had been properly warned. Hospitals say they would have adjusted feeding protocols.
| Lawsuit Element | Enfamil Claims | Similac Claims |
|---|---|---|
| Manufacturer | Mead Johnson / Reckitt | Abbott Laboratories |
| Key Product | Enfamil NeuroPro EnfaCare | Similac Special Care |
| Allegation | Failed to warn of NEC risk | Failed to warn of NEC risk |
| Target Population | Premature infants under 33 weeks | Premature infants under 33 weeks |
Both companies maintain their products are safe and properly labeled. They’ve fought hard in court, and that fight is far from over.
Key Takeaway: The Enfamil Similac lawsuit is a mass tort targeting two formula giants for failing to warn families about NEC risks in premature babies, with more than 1,000 cases now pending in federal court and the litigation gaining speed in 2026.
Similac and Enfamil Lawsuit: Key Defendants
Two major corporations sit at the center of this litigation. Abbott Laboratories manufactures Similac. Mead Johnson Nutrition, now owned by Reckitt Benckiser, makes Enfamil.
Abbott is a Fortune 500 company headquartered in Abbott Park, Illinois. Similac has been one of the best-selling infant formulas in the United States for decades. The company reported billions in nutritional product revenue in recent years.
Mead Johnson has an equally long history. Reckitt Benckiser, a British consumer goods conglomerate, acquired Mead Johnson in 2017 for approximately $17.9 billion. That acquisition means Reckitt now carries the legal exposure from Enfamil claims.
Both defendants have the financial resources to fight this litigation aggressively. They’ve hired top defense firms and challenged plaintiffs at every stage.
- Abbott Laboratories: Maker of Similac, Similac Special Care, Similac Alimentum
- Mead Johnson / Reckitt Benckiser: Maker of Enfamil, Enfamil NeuroPro EnfaCare, Enfamil Premature
- Combined market share: These two companies control roughly 80% of the U.S. infant formula market
The fact that Reckitt acquired Mead Johnson creates an interesting dynamic. Reckitt inherited liability for products sold before the acquisition. Some analysts believe Reckitt may be more motivated to settle than Abbott, given that formula isn’t Reckitt’s core business line.
Abbott, on the other hand, has a deep commitment to its nutritional products division. The company has shown little willingness to concede fault publicly.
NEC Baby Formula Lawsuit Status in 2026
The NEC baby formula lawsuit status in 2026 shows a litigation that’s maturing toward resolution. Discovery is wrapping up, bellwether trials are providing data points, and both sides are calculating their next moves.
Judge Pallmeyer has managed the MDL efficiently since its creation in 2022. The court established a case management order that prioritized bellwether case selection, expert witness challenges, and trial scheduling.
As of 2026, the litigation is in what attorneys call the “post-bellwether evaluation phase.” This is when both sides look at trial outcomes and decide whether a global settlement makes sense or whether more trials are needed.
| Timeline Milestone | Status |
|---|---|
| MDL Creation | 2022 |
| First Bellwether Trial | 2024 (plaintiff verdict against Mead Johnson) |
| Second Bellwether Trial | 2024 (defense verdict for Abbott) |
| Additional Trials | Scheduled through 2026 |
| Settlement Discussions | Ongoing, no public deal yet |
| New Case Filings | Still being accepted |
The split bellwether results mean neither side has a clear advantage. Plaintiffs proved they can win. Defendants proved they can win too. That kind of uncertainty often pushes both sides toward settlement.
Families waiting on the sidelines should know: the litigation is very much alive. Cases are still being filed and accepted into the MDL. But the window won’t stay open forever.
Baby Formula Lawsuit Settlement Amounts
Baby formula lawsuit settlement amounts have not been officially determined because no global settlement exists yet. However, legal analysts and attorneys involved in the litigation have offered projections based on comparable cases and bellwether results.
Individual case values depend heavily on the severity of the child’s injuries. A baby who died from NEC will have a higher case value than a baby who survived after surgery.
Legal experts project the following ranges based on injury severity:
| Injury Level | Projected Settlement Range |
|---|---|
| NEC resulting in death | $1,000,000 to $5,000,000+ |
| NEC requiring surgery with lasting complications | $500,000 to $2,000,000 |
| NEC requiring surgery, full recovery | $250,000 to $750,000 |
| NEC treated without surgery | $50,000 to $250,000 |
These are estimates, not guarantees. Every case is different.
The first bellwether verdict reportedly resulted in a substantial jury award against Mead Johnson. That number sets a benchmark, but appellate challenges and settlement negotiations will likely adjust final payouts.
Factors that increase case value include:
- Death of the infant
- Multiple surgeries required
- Short bowel syndrome diagnosis
- Extended NICU stay (weeks or months beyond the original stay)
- Permanent disabilities from intestinal damage
Families with strong medical records linking formula use to NEC diagnosis will have the strongest cases.
Key Takeaway: No global settlement has been announced, but legal analysts project individual payouts ranging from $50,000 for mild cases to over $5 million for wrongful death, depending on the severity of the child’s NEC injuries.
Similac NEC Lawsuit Payout Estimates
The Similac NEC lawsuit payout depends on whether Abbott settles or continues fighting each case at trial. So far, Abbott has shown more willingness to fight than Mead Johnson.
Abbott won the second bellwether trial in 2024. That defense victory gave the company confidence. But one win doesn’t mean Abbott will prevail in every case, and the company faces hundreds of remaining claims.
Payout estimates for Similac cases mirror the general ranges listed above. However, some attorneys believe Similac cases could settle for slightly different amounts than Enfamil cases, depending on:
- The specific Similac product involved (Special Care vs. standard Similac)
- The gestational age of the infant
- Whether the hospital or parent chose the formula
- The strength of causation evidence in each case
Abbott’s financial resources mean the company can sustain prolonged litigation. But the cost of defending hundreds of individual trials often exceeds the cost of settling. That economic reality pushes even the most aggressive defendants toward resolution.
If Abbott reaches a settlement framework, payouts would likely be structured in tiers based on injury severity. The company would probably require proof that Similac was the primary formula used during the period leading to NEC diagnosis.
Families with Similac claims should keep all NICU feeding records. Those records are the single most valuable piece of evidence in your case.
Enfamil Similac Lawsuit Compensation Breakdown
Compensation in the Enfamil Similac lawsuit covers several categories of damages. It’s not just one lump sum for “having NEC.” The law recognizes different types of harm, and each one adds to the total value.
Here’s how compensation typically breaks down in product liability cases like this:
| Damage Category | What It Covers |
|---|---|
| Medical Expenses | NICU costs, surgeries, follow-up care, medications |
| Future Medical Costs | Ongoing treatment for short bowel syndrome or other lasting conditions |
| Pain and Suffering | Physical pain endured by the infant |
| Emotional Distress | Trauma experienced by parents and family |
| Loss of Quality of Life | Permanent disabilities affecting the child’s future |
| Wrongful Death | Funeral costs, loss of companionship (in fatal NEC cases) |
| Punitive Damages | Punishment for manufacturer misconduct (awarded at trial, not in settlements) |
Medical expenses alone can reach staggering numbers. A NICU stay costs roughly $3,000 to $5,000 per day. Babies with NEC often spend weeks or months in intensive care. A single NEC surgery can cost $100,000 or more.
Punitive damages are the wild card. They’re only awarded at trial, not in settlements. But the possibility of punitive damages gives plaintiffs leverage during settlement negotiations.
The total compensation a family receives will reflect the combined value of all applicable damage categories. Stronger documentation means higher compensation.
Who Qualifies for the Enfamil Lawsuit?
You may qualify for the Enfamil lawsuit if your premature baby was fed Enfamil or Similac in a hospital setting and later developed NEC. The key factors are prematurity, formula exposure, and a confirmed NEC diagnosis.
Here are the general eligibility requirements:
- The baby was born premature (typically before 37 weeks gestational age; strongest cases involve babies born before 33 weeks)
- The baby was fed Enfamil or Similac cow’s milk based formula, usually in a NICU
- The baby was diagnosed with NEC (necrotizing enterocolitis), confirmed by medical records
- The NEC diagnosis occurred within a reasonable time after formula feeding began
- The claim falls within the applicable statute of limitations (varies by state)
Not every baby who developed NEC will qualify. Cases where the baby was exclusively breastfed are not part of this litigation. The formula must have been cow’s milk based, not a hydrolyzed or amino acid formula.
Wrongful death claims are also eligible. If a premature infant died from NEC after being fed these formulas, the family can file a claim.
| Eligibility Factor | Requirement |
|---|---|
| Gestational Age | Born before 37 weeks (strongest: under 33 weeks) |
| Formula Used | Enfamil or Similac cow’s milk based product |
| Diagnosis | Confirmed NEC |
| Timing | NEC developed during or after formula feeding |
| Statute of Limitations | Must file within state deadline |
Key Takeaway: You likely qualify for the Enfamil Similac lawsuit if your premature infant was fed cow’s milk formula in the NICU and received a confirmed NEC diagnosis, but you must file within your state’s statute of limitations.
Premature Infant Formula Lawsuit Claims
Premature infant formula lawsuit claims focus specifically on babies born early, because these infants have underdeveloped digestive systems that make them especially vulnerable to NEC. Full-term babies rarely develop NEC.
The biology matters here. A premature baby’s gut lining is thin and fragile. Cow’s milk proteins are harder to digest than breast milk proteins. When a preterm infant’s immature gut encounters cow’s milk formula, it can trigger an inflammatory response that leads to tissue death.
That’s NEC. And it happens fast. A baby can go from stable to critical within hours.
Claims in this litigation typically fall into two categories:
- Surviving infant claims: The baby had NEC, underwent surgery, and may have lasting medical issues like short bowel syndrome, feeding difficulties, or developmental delays.
- Wrongful death claims: The baby died from NEC or complications caused by NEC.
Both types of claims are active in the MDL. Wrongful death cases generally carry higher compensation values, but surviving infant claims can also reach significant amounts when the child faces lifelong medical needs.
Parents don’t need to prove they personally chose the formula. In most NICU cases, the hospital selected the formula as part of its feeding protocol. That doesn’t weaken your claim. The lawsuit targets the manufacturers, not the hospitals.
Cow’s Milk Formula NEC Risk: What the Science Says
Cow’s milk formula significantly increases the risk of NEC in premature infants compared to breast milk. This isn’t disputed among neonatologists. The medical evidence is extensive and has been building for over two decades.
A landmark 2010 study by Sullivan and colleagues found that an exclusive human milk diet reduced NEC rates by 77% compared to cow’s milk formula feeding. That’s a staggering risk difference.
The Cochrane Review, one of the most respected sources of medical evidence, has consistently found that formula feeding raises NEC risk in preterm infants. Their reviews have been cited in court proceedings during the bellwether trials.
Key scientific findings include:
- Sullivan et al. (2010): 77% reduction in NEC with human milk vs. cow’s milk formula
- Cochrane Review (2019, updated 2023): Formula feeding associated with higher NEC incidence in preterm infants
- American Academy of Pediatrics: Recommends breast milk as the primary nutrition for premature infants, citing NEC risk reduction
- WHO guidance: Supports donor human milk when mother’s own milk is unavailable for preterm babies
| Study / Source | Finding |
|---|---|
| Sullivan et al. (2010) | 77% NEC reduction with human milk diet |
| Cochrane Review (2023) | Formula feeding linked to higher NEC rates |
| AAP Policy | Recommends breast milk for preterm infants |
| WHO Guidelines | Supports donor milk over formula for preterm babies |
The manufacturers’ defense argues that correlation doesn’t equal causation and that NEC is a multifactorial disease. That’s technically true. But the weight of evidence overwhelmingly supports a causal connection between cow’s milk formula and NEC in premature babies.
This science is the foundation of every claim in the litigation. Without it, the cases wouldn’t exist.
What Evidence Do You Need for the Enfamil Similac Lawsuit?
You need medical records showing your baby was premature, was fed Enfamil or Similac, and was diagnosed with NEC. These three elements form the backbone of your case.
Gathering evidence early is critical. Medical records can become harder to obtain as years pass. Hospitals may archive or destroy records after certain retention periods.
Here’s a practical checklist of what you should collect:
- Birth records showing gestational age and birth weight
- NICU admission records documenting the baby’s hospitalization
- Feeding logs and protocols from the NICU (these show which formula was used and when)
- NEC diagnosis records including imaging reports, lab work, and physician notes
- Surgical records if the baby had surgery for NEC
- Discharge summaries from the NICU and any subsequent hospitalizations
- Death certificate (for wrongful death claims)
- Receipts or insurance records for formula purchases (if formula was used at home)
- Follow-up medical records showing ongoing health issues related to NEC
| Evidence Type | Why It Matters |
|---|---|
| NICU feeding logs | Proves which formula was used and when |
| NEC diagnosis records | Confirms the condition |
| Birth records | Establishes prematurity |
| Surgical records | Documents severity of injury |
| Follow-up care records | Shows lasting impact |
The most important single document is the NICU feeding log. This record shows exactly what the baby was fed, on what dates, and in what quantities. Without it, connecting the formula to the NEC diagnosis becomes much harder.
Don’t rely on memory. Get the paperwork.
Key Takeaway: NICU feeding logs are the single most important piece of evidence in your case because they directly link the formula to your baby’s NEC diagnosis, so request them from your hospital as soon as possible.
How to File an Enfamil Similac Lawsuit
Filing an Enfamil Similac lawsuit starts with contacting a law firm that handles NEC baby formula cases. Most firms offer free case evaluations and work on a contingency fee basis, meaning you pay nothing upfront.
Here’s the typical process from start to finish:
Step 1: Free case review. A law firm evaluates your child’s medical history. They look at prematurity, formula exposure, and NEC diagnosis.
Step 2: Sign a retainer agreement. If the firm accepts your case, you sign a representation agreement. Contingency fees typically range from 33% to 40% of the recovery.
Step 3: Gather medical records. The firm requests your child’s NICU records, feeding logs, and other documentation. You can help by providing hospital names and dates.
Step 4: File the complaint. Your attorney files a formal legal complaint, usually in federal court. The case gets assigned to MDL 3026 in the Northern District of Illinois.
Step 5: Discovery and case development. Your attorneys work with medical experts to build the causation argument. This phase can take months.
Step 6: Settlement negotiation or trial. Your case either settles as part of a group resolution or proceeds to individual trial.
| Filing Step | What Happens |
|---|---|
| Case Review | Law firm evaluates eligibility for free |
| Retainer Signed | You agree to representation (no upfront cost) |
| Records Gathered | Firm collects NICU and medical documentation |
| Complaint Filed | Case enters federal MDL 3026 |
| Discovery | Expert review, depositions, evidence exchange |
| Resolution | Settlement or trial |
You don’t need to live in Illinois to file. The MDL accepts cases from families across the country. Your attorney handles all the logistics.
Enfamil Similac Lawsuit Deadline: When to Act
The deadline to file an Enfamil Similac lawsuit depends on your state’s statute of limitations. There is no single national deadline. Each state sets its own time limit for product liability and personal injury claims.
Most states allow between 2 and 6 years to file. The clock usually starts on the date of the NEC diagnosis or, in some states, the date you discovered (or should have discovered) that the formula caused the condition.
| State | Statute of Limitations |
|---|---|
| California | 2 years from discovery |
| Texas | 2 years from injury |
| New York | 3 years from injury |
| Florida | 4 years from injury (recently changed; check current law) |
| Illinois | 2 years from injury |
| Pennsylvania | 2 years from injury |
Some states have special rules for minors. When the injured person is a child, the statute of limitations may be “tolled,” meaning the clock doesn’t start until the child reaches a certain age. This can extend filing deadlines significantly.
But don’t count on tolling provisions saving your case. The safest approach is to file as soon as possible.
Missing the deadline means losing your right to compensation permanently. No exceptions. No appeals. The court will dismiss your case, and that’s the end of it.
If your child’s NEC diagnosis happened years ago, contact an attorney immediately to check whether you still have time.
NEC Lawsuit Bellwether Trial Results
Bellwether trials are test cases selected from the larger MDL to give both sides a preview of how juries might react. The results guide settlement negotiations for the remaining cases. In the NEC litigation, bellwether outcomes have been mixed.
The first bellwether trial took place in 2024 against Mead Johnson. The jury sided with the plaintiff family, finding that Mead Johnson failed to adequately warn about NEC risks associated with Enfamil products. Reports indicate a substantial damages award.
The second bellwether trial, also in 2024, involved Abbott and its Similac products. This time, the jury ruled in favor of Abbott. The defense argued successfully that the infant’s NEC was caused by other factors, not the formula.
- Trial 1 (Mead Johnson): Plaintiff verdict; significant damages awarded
- Trial 2 (Abbott): Defense verdict; jury found insufficient causation evidence
What do split verdicts mean for you? They mean the litigation is competitive. Neither side dominates. That typically leads to settlement rather than rolling the dice on hundreds more trials.
For plaintiffs, the Mead Johnson verdict proves juries can and will hold manufacturers responsible. For defendants, the Abbott verdict shows that winning is possible when causation evidence is weaker.
Additional bellwether trials are expected through 2026. Each result shifts the settlement calculus. More plaintiff wins increase settlement pressure. More defense wins reduce it.
Key Takeaway: Split bellwether verdicts in 2024 created pressure on both sides, and attorneys expect this dynamic to push toward settlement negotiations in 2026 rather than hundreds of individual trials.
The Abbott Mead Johnson Lawsuit
The Abbott Mead Johnson lawsuit refers to the combined litigation targeting both formula manufacturers. Abbott makes Similac. Mead Johnson (owned by Reckitt Benckiser) makes Enfamil. These two companies face the vast majority of NEC formula claims.
Abbott Laboratories is headquartered in Illinois. The company generated over $40 billion in total revenue in recent years. Its nutrition division, which includes Similac, is a significant revenue driver.
Reckitt Benckiser acquired Mead Johnson in 2017. That deal brought Enfamil under Reckitt’s corporate umbrella. Reckitt is a London-based company with a portfolio spanning consumer health and hygiene products.
Both companies have taken different defensive approaches:
| Company | Legal Strategy |
|---|---|
| Abbott | Aggressive defense; won bellwether trial; challenges causation evidence |
| Mead Johnson / Reckitt | Lost bellwether trial; may be more open to settlement discussions |
Reckitt has signaled in public filings that it takes the NEC litigation seriously as a financial risk. Abbott has been quieter publicly but equally aggressive in court.
Some legal analysts believe Reckitt might pursue a separate settlement for Enfamil cases before Abbott settles Similac claims. That would create a two-track resolution, which has precedent in other mass tort cases.
Regardless of corporate strategy, families can file claims against either or both companies. Many babies in NICUs were fed both Enfamil and Similac at different points during their stay.
Is the Baby Formula Lawsuit a Class Action?
The baby formula lawsuit is not a class action. It is a mass tort consolidated as a multidistrict litigation, or MDL. The distinction matters because it affects how your case is handled and how compensation is determined.
In a class action, one verdict or settlement applies equally to all members of the class. Everyone gets the same payout. In a mass tort MDL, each case is treated individually. Your compensation depends on the specific facts of your child’s situation.
| Feature | Class Action | Mass Tort MDL |
|---|---|---|
| Individual cases? | No; one case represents all | Yes; each case is separate |
| Same payout for everyone? | Usually yes | No; varies by injury severity |
| Opt-in or opt-out? | Varies | Each plaintiff files separately |
| Personalized evidence? | Minimal | Required for each case |
| Control over your case? | Low | High |
This structure benefits families with serious injuries. If your child died from NEC or needed multiple surgeries, your case is worth significantly more than a mild NEC case. A class action would flatten that difference.
The MDL structure keeps cases together for pretrial purposes like discovery and expert challenges. But when it comes to settlement or trial, each case stands on its own merits.
You need your own attorney. You need your own evidence. And your payout will reflect your child’s specific experience.
Frequently Asked Questions
How much money can I get from the Enfamil Similac lawsuit?
Most legal projections range from $50,000 to over $5 million per case.
The exact amount depends on the severity of your child’s NEC, whether surgery was needed, and whether the child survived.
Wrongful death cases carry the highest potential compensation.
Who qualifies to file an Enfamil or Similac NEC lawsuit in 2026?
You may qualify if your premature baby was fed cow’s milk based Enfamil or Similac and was diagnosed with NEC.
The baby must have been born before 37 weeks gestational age, with the strongest cases involving infants born before 33 weeks.
You must file within your state’s statute of limitations.
What is the deadline to file an Enfamil Similac lawsuit?
There is no single national deadline; it depends on your state’s statute of limitations.
Most states allow 2 to 6 years from the date of injury or discovery.
Contact an attorney now to confirm your specific deadline before time runs out.
Is the NEC baby formula lawsuit a class action or mass tort?
It is a mass tort, not a class action.
Each case is handled individually within MDL No. 3026 in the Northern District of Illinois.
Your compensation will be based on your child’s specific injuries and evidence.
What evidence do I need to file an Enfamil Similac lawsuit claim?
You need NICU feeding logs, birth records showing prematurity, and medical records confirming a NEC diagnosis.
Surgical records, follow-up care documents, and a death certificate (if applicable) strengthen your case.
Request these records from your hospital as soon as possible.
Take Action Before Time Runs Out
The Enfamil Similac lawsuit is heading toward potential resolution in 2026. Families who file now position themselves to benefit from any settlement framework that emerges.
Don’t wait for a headline to tell you it’s too late. Gather your child’s medical records, check your state’s filing deadline, and connect with an attorney who handles NEC formula cases.
Your window is open. Use it.
